Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (3044)
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
3,321
Price
$20.88
Total Value
$69.34K
Shares Held After
71,322
% of Holdings
4.4%
Syndax Pharmaceuticals Inc (SNDX)
Podlesak Dennis — Director
Shares
8,000
Price
$14.21
Total Value
$113.72K
Shares Held After
239,763
% of Holdings
3.2%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$32.07
Total Value
$240.53K
Shares Held After
32,316
% of Holdings
18.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$599.30
Total Value
$23.97K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
919
Price
$597.66
Total Value
$549.25K
Shares Held After
324,483
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,355
Price
$596.86
Total Value
$808.75K
Shares Held After
325,402
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,678
Price
$595.88
Total Value
$999.89K
Shares Held After
326,757
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,248
Price
$594.89
Total Value
$742.43K
Shares Held After
328,435
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,540
Price
$593.88
Total Value
$914.57K
Shares Held After
329,683
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,563
Price
$592.97
Total Value
$926.81K
Shares Held After
331,223
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,104
Price
$591.90
Total Value
$653.46K
Shares Held After
332,786
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
53
Price
$590.43
Total Value
$31.29K
Shares Held After
333,890
% of Holdings
0.0%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
1,044,990
Price
$0.02
Total Value
$17.76K
Shares Held After
95,481,309
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,881
Price
$28.27
Total Value
$335.88K
Shares Held After
377,802
% of Holdings
3.0%
Rapport Therapeutics, Inc. (RAPP)
HEALY JAMES — Director
Shares
6,933
Price
$21.00
Total Value
$145.59K
Shares Held After
25,267
% of Holdings
27.4%
Rapport Therapeutics, Inc. (RAPP)
HEALY JAMES — Director
Shares
3,772
Price
$21.00
Total Value
$79.21K
Shares Held After
14,924
% of Holdings
25.3%
Rapport Therapeutics, Inc. (RAPP)
HEALY JAMES — Director
Shares
6,395
Price
$21.00
Total Value
$134.29K
Shares Held After
17,990
% of Holdings
35.5%
Rapport Therapeutics, Inc. (RAPP)
HEALY JAMES — Director
Shares
952,380
Price
$21.00
Total Value
$20.00M
Shares Held After
2,815,707
% of Holdings
33.8%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
200,000
Price
$36.59
Total Value
$7.32M
Shares Held After
1,199,154
% of Holdings
14.3%
Immunovant, Inc. (IMVT)
Girao Tiago — Chief Financial Officer
Shares
6,606
Price
$28.50
Total Value
$188.27K
Shares Held After
234,192
% of Holdings
2.7%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,469
Price
$18.62
Total Value
$27.35K
Shares Held After
103,665
% of Holdings
1.4%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
2,252
Price
$18.62
Total Value
$41.93K
Shares Held After
396,878
% of Holdings
0.6%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
753
Price
$18.62
Total Value
$14.02K
Shares Held After
222,904
% of Holdings
0.3%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
312,000
Price
$0.02
Total Value
$5.77K
Shares Held After
94,436,319
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
200
Price
$28.90
Total Value
$5.78K
Shares Held After
377,802
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,681
Price
$28.44
Total Value
$332.21K
Shares Held After
378,002
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$588.39
Total Value
$47.07K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
986
Price
$587.27
Total Value
$579.04K
Shares Held After
324,523
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,086
Price
$586.37
Total Value
$1.81M
Shares Held After
325,509
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,902
Price
$585.36
Total Value
$1.11M
Shares Held After
328,595
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,625
Price
$584.43
Total Value
$1.53M
Shares Held After
330,497
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
821
Price
$583.50
Total Value
$479.05K
Shares Held After
333,122
% of Holdings
0.2%
ACTUATE THERAPEUTICS, INC. (ACTU)
SCHMITT DANIEL M — Director
Shares
140,844
Price
$0.35
Total Value
$50.00K
Shares Held After
442,560
% of Holdings
31.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
8,881
Price
$27.53
Total Value
$244.49K
Shares Held After
377,802
% of Holdings
2.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
3,000
Price
$26.58
Total Value
$79.74K
Shares Held After
386,683
% of Holdings
0.8%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
10,707
Price
$2.40
Total Value
$25.70K
Shares Held After
3,022,456
% of Holdings
0.4%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
6,903
Price
$366.22
Total Value
$2.53M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
3,965
Price
$365.43
Total Value
$1.45M
Shares Held After
6,903
% of Holdings
36.5%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
2,841
Price
$363.95
Total Value
$1.03M
Shares Held After
10,868
% of Holdings
20.7%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
8,148
Price
$363.24
Total Value
$2.96M
Shares Held After
13,709
% of Holdings
37.3%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
2,331
Price
$362.35
Total Value
$844.64K
Shares Held After
21,857
% of Holdings
9.6%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
320
Price
$360.64
Total Value
$115.40K
Shares Held After
24,188
% of Holdings
1.3%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,280
Price
$359.72
Total Value
$460.44K
Shares Held After
24,508
% of Holdings
5.0%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,681
Price
$358.75
Total Value
$603.05K
Shares Held After
25,788
% of Holdings
6.1%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,239
Price
$357.54
Total Value
$442.99K
Shares Held After
27,469
% of Holdings
4.3%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,440
Price
$355.62
Total Value
$512.09K
Shares Held After
28,708
% of Holdings
4.8%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
880
Price
$355.56
Total Value
$312.89K
Shares Held After
30,148
% of Holdings
2.8%
Rallybio Corp (RLYB)
Lieber Jonathan I — Chief Financial Officer
Shares
599
Price
$16.04
Total Value
$9.61K
Shares Held After
15,551
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$592.84
Total Value
$47.43K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$592.05
Total Value
$355.23K
Shares Held After
324,523
% of Holdings
0.2%
3044 transactions